Vivos Change To Netincome from 2010 to 2025

VVOS Stock  USD 3.47  0.08  2.36%   
Vivos Therapeutics Change To Netincome yearly trend continues to be comparatively stable with very little volatility. Change To Netincome will likely drop to about 3.7 M in 2025. From the period from 2010 to 2025, Vivos Therapeutics Change To Netincome quarterly data regression had r-value of  0.75 and coefficient of variation of  54.65. View All Fundamentals
 
Change To Netincome  
First Reported
2010-12-31
Previous Quarter
4.4 M
Current Value
3.7 M
Quarterly Volatility
1.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vivos Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vivos Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 0.0 or Interest Income of 141.3 K, as well as many indicators such as Price To Sales Ratio of 1.2, Dividend Yield of 0.0 or PTB Ratio of 34.88. Vivos financial statements analysis is a perfect complement when working with Vivos Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Vivos Therapeutics Correlation against competitors.
For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.

Latest Vivos Therapeutics' Change To Netincome Growth Pattern

Below is the plot of the Change To Netincome of Vivos Therapeutics over the last few years. It is Vivos Therapeutics' Change To Netincome historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vivos Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Change To Netincome10 Years Trend
Slightly volatile
   Change To Netincome   
       Timeline  

Vivos Change To Netincome Regression Statistics

Arithmetic Mean2,613,212
Geometric Mean2,311,790
Coefficient Of Variation54.65
Mean Deviation1,234,873
Median1,570,656
Standard Deviation1,428,018
Sample Variance2T
Range4.5M
R-Value0.75
Mean Square Error957.1B
R-Squared0.56
Significance0.0008
Slope224,851
Total Sum of Squares30.6T

Vivos Change To Netincome History

20253.7 M
20244.4 M
20213.8 M
20206.1 M
20192.1 M

About Vivos Therapeutics Financial Statements

Vivos Therapeutics shareholders use historical fundamental indicators, such as Change To Netincome, to determine how well the company is positioned to perform in the future. Although Vivos Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Vivos Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Vivos Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change To Netincome4.4 M3.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vivos Stock Analysis

When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.